Leventa 1 mg/ml oral solution for dogs
Leventa 1 mg/ml oral solution for dogs
Authorised
- Levothyroxine sodium
Product identification
Medicine name:
Leventa 1 mg/ml oral solution for dogs
Leventa 1 mg/ml Roztwór doustny
Active substance:
- Levothyroxine sodium
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Levothyroxine sodium1.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Oral solution
Withdrawal period by route of administration:
-
Oral use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QH03AA01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Poland
Package description:
- 30 mL amber glass bottle with a transparent LDPE insert and with a white HDPE child-resistant cap with tamper-proof closure in a printed carton. A 1 ml oral syringe graduated in 0.05 ml increments is supplied with the product. Pack size: 1 x 30 ml
- 30 mL amber glass bottle with a transparent LDPE insert and with a white HDPE child-resistant cap with tamper-proof closure in a printed carton. A 1 ml oral syringe graduated in 0.05 ml increments is supplied with the product. Pack size: 6 x 30 ml
- 30 mL amber glass bottle with a transparent LDPE insert and with a white HDPE child-resistant cap with tamper-proof closure in a printed carton. A 1 ml oral syringe graduated in 0.05 ml increments is supplied with the product. Pack size: 12 x 30 ml
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
- Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Intervet Productions
Responsible authority:
- Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
- 1765
Reference member state:
-
Ireland
Procedure number:
- IE/V/0182/001
Concerned member states:
-
Austria
-
Belgium
-
Czechia
-
France
-
Germany
-
Greece
-
Hungary
-
Italy
-
Luxembourg
-
Netherlands
-
Poland
-
Portugal
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
Summary of Product Characteristics
English (PDF)
Download Published on: 11/02/2022
Polish (PDF)
Published on: 4/02/2022
How useful was this page?:
